Symptomatic and Phenotypic Evaluation of Chronic Pelvic Pain Syndrome and Chronic Prostatitis and Comparison of Conventional Versus UPOINT Classification-Based Medications on Its Management

Authors

  • Ashish Ghanghoria Associate professor, Department of urology, Superspeciality Hospital Shyam Shah Medical College, Rewa Madhya Pradesh, India
  • Mukund Pandey Assistant professor, Department of General surgery, Shyam Shah medical college Rewa, India
  • Nidhi Pandey Assistant professor, Department of Anesthesia, Shyam Shah Medical College Rewa, India
  • Krishna Kumar Uikey Senior Resident, Department of surgery, Shyam Shah Medical College, Rewa, Madhya Pradesh, India
  • Mohanraj C Junior Resident, Department of Surgery, Shyam Shah Medical College, Rewa Madhya Pradesh, India

DOI:

https://doi.org/10.32553/ijmbs.v9i6.3155

Keywords:

Chronic pelvic pain

Abstract

Background: Both Chronic Prostatitis (CP) and Chronic Pelvic discomfort Syndrome (CPPS) are complicated urological disorders marked by lower urinary tract symptoms, chronic pelvic discomfort, and a marked reduction in quality of life. Because these illnesses are diverse and complicated, traditional symptom-based treatment frequently produces uneven results. By grouping patients into discrete clinical categories, the UPOINT phenotypic categorization system provides an organized, customized approach that may enhance treatment results.

Objectives: The purpose of this study was to assess the phenotypic and symptomatic features of CPPS and CP and to compare the efficacy of UPOINT classification-guided therapy with traditional symptom-based treatment in managing the disease.

Materials and Methods: A prospective comparison study included one hundred male patients with CP or CPPS. Patients were randomly assigned to two groups: While Group A received normal treatment, Group B received tailored therapy based on UPOINT. The severity of symptoms and the efficacy of treatment were assessed using the NIH Chronic Prostatitis Symptom Index (NIH-CPSI), Visual Analogue Scale (VAS), International Prostate Symptom Score (IPSS), and Male Genitourinary Pain Index (GUPI). Follow-up evaluations were done at baseline, 15 days, 1 month, and 3 months.

Results: When compared to patients receiving conventional treatment, those treated with UPOINT-based therapy showed noticeably higher improvements in NIH-CPSI total scores, pain severity, urine symptoms, and quality-of-life indicators. A greater response to targeted multimodal therapy and higher baseline symptom levels were linked to multidomain participation.

Conclusion: When it comes to improving clinical outcomes for CPPS and CP, UPOINT classification-guided care outperforms traditional symptom-based treatment. For efficient illness management, phenotypic stratification should be included into standard clinical practice since it allows for tailored therapy.

Keywords: Chronic pelvic pain syndrome; chronic prostatitis; UPOINT classification; NIH-CPSI; Phenotypic evaluation; personalized therapy

Downloads

Published

2025-12-31

How to Cite

Ghanghoria, A. ., Pandey, M. ., Pandey, N. ., Uikey, K. K. ., & C, M. . (2025). Symptomatic and Phenotypic Evaluation of Chronic Pelvic Pain Syndrome and Chronic Prostatitis and Comparison of Conventional Versus UPOINT Classification-Based Medications on Its Management. International Journal of Medical and Biomedical Studies, 9(6). https://doi.org/10.32553/ijmbs.v9i6.3155

Issue

Section

Articles